1Sirvent J J,Salvado M T,Santafe M,et al.p53 in breast cancer.Its relation to histological grade,lymph-node status,hormone receptors,cell-proliferation fraction (Ki-67) and c-erbB-2.Immunohistochemical study of 153 cases[J].Histol Histopathol,1995,10(3):531-539.
2Ioffe O B,Papadimitriou J C,Drachenberg C B.Correlation of proliferation indices,apoptosis,and related oncogene expression (bcl-2 and cerbB-2) and p53 in proliferative,hyperplastic,and malignant endometrium[J].Hum Pathol,1998,29(10):1150-1159.
3Halperin R,Zehavi S,Habler L,et al.Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometriurn[J].Eur J Gynaecol Oncol,2001,22(2):122-126.
4Ratovitski E A,Patturajan M,Hibi K,et al.p53 associates with and targets Delta Np63 into a protein degradation pathway[J].Proc Natl Acad Sci U S A,2001,98(4):1817-1822.
5Dohn M,Zhang S,Chen X.p63alpha and Delta Np63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes[J].Oncogene,2001,20(25):3193-3205.
6Yang A,Kaghad M,Wang Y,et al.p63,a p53 homolog at 3q27-29,encodes multiple products with transactivating,death inducing,and dominate-negative activities[J].Mol Cell,1998,2(3):305-316.
7Choi H R,Batsakis J G,Zhan F,et al.Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis[J].Hum Pathol,2002,33(2):158-164.
8Ribeiro-Silva A,Zambelli-Ramalho L N,Britto-Garcia S,et al.The relationship between p63 and p53 expression in normal and neoplastic breast tissue[J].Arch Pathol Lab Med,2003,127(3):336-340.
